Design Therapeutics, Inc.

Q3 2026 13F Holders

Symbol
DSGN
CUSIP
25056L103
Type
Equity
Class
COM
Num filers
142
Total reported value, excl. options
$670M
Manager Report Date Value ($000) Shares